SUPERIOR SUPPLEMENTS INC
10KSB40, EX-27.1, 2000-09-28
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: SUPERIOR SUPPLEMENTS INC, 10KSB40, EX-10.15, 2000-09-28
Next: NUVEEN FLAGSHIP MULTISTATE TRUST III, 485BPOS, 2000-09-28



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                                JUN-30-2000
<PERIOD-START>                                   JUL-01-1999
<PERIOD-END>                                     JUN-30-2000
<CASH>                                                 7,406
<SECURITIES>                                               0
<RECEIVABLES>                                          9,240
<ALLOWANCES>                                               0
<INVENTORY>                                          156,792
<CURRENT-ASSETS>                                     239,307
<PP&E>                                             1,948,131
<DEPRECIATION>                                       815,713
<TOTAL-ASSETS>                                     1,400,636
<CURRENT-LIABILITIES>                              1,988,378
<BONDS>                                                    0
                                    400
                                                0
<COMMON>                                                 500
<OTHER-SE>                                         (588,642)
<TOTAL-LIABILITY-AND-EQUITY>                       1,400,636
<SALES>                                            6,102,473
<TOTAL-REVENUES>                                   6,102,473
<CGS>                                              6,927,136
<TOTAL-COSTS>                                      6,927,136
<OTHER-EXPENSES>                                           0
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                    17,952
<INCOME-PRETAX>                                  (1,504,262)
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                              (1,504,262)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                     (1,504,262)
<EPS-BASIC>                                           (0.38)
<EPS-DILUTED>                                         (0.38)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission